Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ward, Tokyo 160-8582, Japan.
J Plast Reconstr Aesthet Surg. 2012 Jun;65(6):814-7. doi: 10.1016/j.bjps.2011.10.012. Epub 2011 Nov 23.
The resection of neurofibromas in Von Recklinghausen's disease (NF-1) is frequently complicated by potentially life-threatening intraoperative and postoperative hemorrhage, due to the high tumor vascularity and tissue friability.
This report describes a novel technique for the resection of neurofibromas using the LigaSure™ (Valleylab, Tyco International Healthcare, Boulder, CO) vessel sealing system. We compared five cases of NF-1 tumor removal which used this vessel sealing system, with six cases that did not, and recorded the intraoperative and postoperative blood loss, length of hospitalization, and postoperative complications.
In all cases employing the LigaSure™, the perioperative blood loss was less than 600 ml (30 ∼ 570 ml), and no patient developed a postoperative hematoma or other bleeding complications. In contrast, the cases not using the LigaSure™ had greater blood loss as well as a higher rate of postoperative hematomas.
The LigaSure™ provides excellent hemostasis with few complications when used for neurofibroma removal.
由于神经纤维瘤的高度血管化和组织脆弱性,在 von Recklinghausen 病(NF-1)中切除神经纤维瘤常常会导致术中及术后潜在危及生命的出血。
本报告介绍了一种使用 LigaSure™(Valleylab,泰科国际医疗保健公司,博尔德,CO)血管密封系统切除神经纤维瘤的新方法。我们比较了使用该血管密封系统的 5 例 NF-1 肿瘤切除病例与未使用该系统的 6 例病例,记录了术中及术后出血量、住院时间和术后并发症。
所有使用 LigaSure™的病例中,围手术期出血量均少于 600ml(30∼570ml),无患者发生术后血肿或其他出血并发症。相比之下,未使用 LigaSure™的病例出血量更大,且术后血肿发生率更高。
当用于切除神经纤维瘤时,LigaSure™ 可提供良好的止血效果,且并发症较少。